Results 241 to 250 of about 95,722 (299)

PNGaseL from Flavobacterium akiainvivens targets a diverse range of N-glycan structures

Bakshani CR, Urbanowicz PA, Tortosa CB, Diaz JMM, Kujawska M, Ojuri TO, Hall LJ, Spencer DI, Bolam DN, Crouch LI.   +9 more
europepmc   +1 more source

The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC. [PDF]

Oncogenesis
Huang HC, Huang YL, Chen YJ, Wu HY, Hsu CL, Kao HF, Liao BC, Hsieh MS, Lin NY, Liao YH, Chen HL, Chen CN, Chen TC, Wang CP, Yang TL, Huang MC, Lin MC, Lou PJ.   +17 more
europepmc   +1 more source

Degradomics for large‐scale mechanistic insights on proteases and proteolysis in human health

The FEBS Journal, EarlyView.
Proteolysis has an important role in human disease but remains relatively unexplored. Degradomics, the uncovering of proteolysis in tissues, cells, and proteins, uses mass spectrometry‐based terminomics to identify protein termini occurring therein (forward degradomics) and to define the actions of proteases (reverse degradomics).
Daniel R. Martin, Sumit Bhutada, Suneel S. Apte   +2 more
wiley   +1 more source

Trafficking and localization of Golgi-resident <i>N</i>-glycan processing enzymes in plants. [PDF]

Front Plant Sci
Dünser K, Schoberer J.
europepmc   +1 more source

A Novel Diagnostic Approach for Hepatocellular Carcinoma Using Glycosylated Ferritin

Hepatology Research, EarlyView.
The percentage of glycosylated ferritin relative to total ferritin (%GF) is a novel biomarker for hepatocellular carcinoma (HCC), showing diagnostic performance comparable to that of AFP and DCP. We developed the GFAD index by integrating age, sex, %GF, AFP, and DCP, achieving improved diagnostic accuracy with high sensitivity and specificity. ABSTRACT
Akiyo Ishiguro, Yutaka Suehiro, Issei Saeki, Maho Egusa, Norikazu Tanabe, Toshihiko Matsumoto, Tsuyoshi Ishikawa, Yuki Kunimune, Toshihiko Kobayashi, Mitsuaki Nishioka, Taro Takami, Takahiro Yamasaki   +11 more
wiley   +1 more source

Dose-response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B. [PDF]

Hepatol Int
Zhang C, Liu Y, Wang L, Liu X, Chen C, Zhang J, Zhang C, Wang G, Zhuang H, Zhao H, China HepB-Related Fibrosis Assessment Research Group.   +10 more
europepmc   +1 more source

Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma. [PDF]

J Proteome Res
Silsirivanit A, Alvarez MRS, Grijaldo-Alvarez SJ, Gogte R, Kitkhuandee A, Piyawattanametha N, Seubwai W, Luang S, Panawan O, Mahalapbutr P, Vaeteewoottacharn K, Sawanyawisuth K, Let-Itthiporn W, Saengboonmee C, Duangthongphon P, Jingjit K, Pankongsap A, Waraasawapati S, Aphivatanasiri C, Lebrilla CB.   +19 more
europepmc   +1 more source

LacdiNAc synthase B4GALNT3 has a unique PA14 domain and suppresses N-glycan capping. [PDF]

J Biol Chem
Tokoro Y, Nagae M, Nakano M, Harduin-Lepers A, Kizuka Y.   +4 more
europepmc   +1 more source

Plasma <i>N</i>-Glycan Profiling Enhances Diagnostic Precision in Multiple Sclerosis, AQP4-Ab NMOSD, and MOGAD. [PDF]

Neurol Neuroimmunol Neuroinflamm
Kacerova T, Sealey M, Saldana L, Xiong W, Woodhall MR, Waters PJ, Sénard T, Cheeseman J, Urbanowicz PA, Elgood-Hunt G, Spencer DIR, McCullagh JSO, Leite MI, DeLuca GC, Palace J, Anthony DC, Yeo T, Probert F.   +17 more
europepmc   +1 more source

N-glycan core tri-fucosylation requires Golgi α-mannosidase III activity that impacts nematode growth and behavior. [PDF]

J Biol Chem
Kendler J, Wӧls F, Thapliyal S, Arcalis E, Gabriel H, Kubitschek S, Malzl D, Strobl MR, Palmberger D, Luber T, Unverzagt C, Paschinger K, Glauser DA, Wilson IBH, Yan S.   +14 more
europepmc   +1 more source